Prenatal Methyl Nutrient Availability Shapes Mesolimbic Dopaminergic Circuitry and Systemic Inflammation in Wistar Rat Offspring of Both Sexes Authors: Cassia Di Pierdomenico, William J. J. Cook, Jianzhang Dong, Gia V. Shelp, Elizabeth M. Poole, Sarah E. Burns, Clara E. Cho Published: 2026 ABSTRACT ABSTRACTThe dopaminergic system constitutes a principal element of the reward neurocircuitry and is responsive to influences encountered early in life. Methylation potential, shaped by nutrients involved in one‐carbon metabolism, intersects with immune signaling and dopaminergic receptor, creating a broader metabolic network through which early life nutrition may alter neurobehavioral outcomes. We have shown that methyl nutrient imbalance between folic acid and choline during pregnancy produces offspring with higher body weight and perturbed methylation potential. However, whether these effects reflect disruptions in the dopaminergic receptor expression and systemic inflammation, and the capacity of betaine (a direct methyl donor) to modify responses across different nutritional contexts remain unknown. To address this, primiparous Wistar rats were randomly assigned to either a recommended vitamin or high folic acid/low choline diet, with or without betaine supplementation during pregnancy, then switched to a control diet during lactation. One female and one male offspring from each dam were followed for 12 weeks post‐weaning under an obesogenic environment. Prenatal micronutrient composition produced distinct patterns of activity in offspring across the light–dark cycle, revealing behavioral signatures of both imbalance and betaine supplementation. Betaine alone reduced body weight and food intake, and provided partial protection against the metabolic consequences of the imbalanced micronutrient diet. Dopaminergic receptor gene expression was responsive to prenatal micronutrient exposure, with treatment × sex interactions restricted to the ventral tegmental area (VTA) and betaine modifying receptor patterns across both the VTA and nucleus accumbens. Catechol‐O‐methyltransferase expression was altered consistent with changes in S‐adenosylmethionine and the S‐adenosylmethionine: S‐adenosylhomocysteine ratio across groups. Higher C‐reactive protein concentrations occurred under micronutrient imbalance, but remained unchanged with betaine supplementation. In conclusion, gestational intake of high folic acid and low choline disturbs dopaminergic, metabolic and immune outcomes in offspring, whereas betaine may serve as a potential modulator capable of mitigating these effects. Abbreviations analysis of variance anterior–posterior betaine supplementation group (recommended vitamin diet with betaine‐supplemented water) Comprehensive Lab Animal Monitoring System catechol‐O‐methyltransferase control group (recommended vitamin diet with untreated water) C‐reactive protein dopamine receptor D1 dopamine receptor D2 dorsoventral enzyme‐linked immunosorbent assay glyceraldehyde‐3‐phosphate dehydrogenase high folic acid/low choline group (high folic acid/low choline diet with untreated water) high folic acid/low choline group with betaine supplementation (high folic acid/low choline diet with betaine‐supplemented water) mediolateral nucleus accumbens recommended vitamin S‐adenosylhomocysteine S‐adenosylmethionine ventral tegmental area Introduction Locomotor behaviors are shaped by complex neural circuits, and perturbations in these networks are posited to underlie the pathogenesis of metabolic and neuropsychiatric disorders (Lenard and Berthoud 2008; Pessoa 2008). Pivotal to these behaviors, the dopaminergic system is recognized as a major reward‐related hub in the brain that governs motivation and reward processing (Speranza et al. 2021). This system originates in the ventral tegmental area (VTA) and projects to the nucleus accumbens (NAc), forming the mesolimbic reward pathway (Alcaro et al. 2007), which has been identified to be sensitive to environmental inputs (Wu et al. 2023), including diet‐induced shifts in epigenetic regulation (Vucetic et al. 2012). Given this sensitivity, there is growing interest in how nutritional factors modulate dopaminergic function, and its relevance to health and disease (Franco et al. 2021; Kravitz et al. 2016). Methyl nutrients, such as folate, choline and betaine, play active roles in one‐carbon metabolism (Ducker and Rabinowitz 2017) and support the generation of S‐adenosylmethionine (SAM), which is the universal methyl donor (Dusa et al. 2025). SAM contributes to epigenetic regulation through methylation of various substrates and is then converted to S‐adenosylhomocysteine (SAH) (Abdelraheem et al. 2022), with the SAM:SAH ratio broadly known as an indicator of cellular methylation potential (Cantoni 1985). Currently, both over‐ and under‐consumption of methyl nutrients are prevalent in North American populations (Maruvada et al. 2020; Lamers et al. 2018; Wallace et al. 2018). This imbalance is evident during pregnancy, where folic acid (the supplemental form of folate) intake is often excessive due to widespread supplementation and food fortification, whereas choline intake remains below the Adequate Intake recommendation (Wiedeman et al. 2024; Moore et al. 2020; St‐Laurent et al. 2023; Fardous and Heydari 2023; Wallace and Fulgoni 2017). Our previous work demonstrated that excessive intake of folic acid during pregnancy, in the absence of choline, leads to female and male offspring with increased body weight and disrupted one‐carbon metabolism, characterized by reduced methylation potential compared to recommended intake of prenatal micronutrients (Shelp et al. 2024). In contrast, choline supplementation during pregnancy improved offspring metabolic outcomes, including enhanced insulin sensitivity and lower body weight and food intake relative to untreated controls (Dong, Shelp, et al. 2025). Network analysis identified betaine utilization as a central metabolic node (Shelp et al. 2024), emphasizing the importance of betaine in the regulation of one‐carbon metabolism and methyl donor availability. Here, we extend this work by examining how metabolic outcomes are shaped by betaine supplementation, alone or within an imbalanced micronutrient environment. For the latter, we were interested in recapitulating conditions that more closely reflect human dietary patterns, specifically high folic acid intake co‐occurring with insufficient (but not absent) choline, and whether betaine provides the capacity to normalize offspring outcomes. Methyl donor availability intersects with dopaminergic circuits (McKee and Reyes 2018), as catechol‐O‐methyltransferase (COMT) is a key enzyme regulating catecholamine turnover through methylation reactions that require SAM (Axelrod and Tomchick 1958; Mannisto and Kaakkola 1999). COMT is known to be highly expressed in cortical regions (Matsumoto et al. 2003), but also extends across subcortical structures including the VTA and NAc (Kaakkola et al. 1987; Schendzielorz et al. 2013). Within these regions, dopamine receptor D1 (DRD1) and dopamine receptor D2 (DRD2) represent the principal postsynaptic targets of dopamine modulating circuit function and behavioral output (Beaulieu and Gainetdinov 2011; Nakamura et al. 2014). Increasing evidence also shows that immune‐derived signals shape the dopaminergic system (Felger and Treadway 2017; Bekhbat et al. 2025), with peripheral inflammatory markers such as C‐reactive protein (CRP) linked with altered dopamine receptor availability (Crine et al. 2025). Importantly, availability of SAM has been shown to shift cytokine profiles (Pfalzer et al. 2014), creating an additional pathway through which gestational nutrition may shape offspring dopaminergic function. Together, this convergence of epigenetic and immune plasticity establishes the mesolimbic system as a centerpoint where metabolic and behavioral outcomes are integrated. These intersecting pathways motivate our hypothesis that gestational intake of methyl nutrient imbalance perturbs offspring dopaminergic function through methylation and immune signaling, and that betaine supplementation may mitigate these disruptions. Our overarching objective was to define how methyl nutrient composition influences offspring metabolic, dopaminergic and inflammatory outcomes, thereby providing insight into mechanisms through which early nutrition influences long‐term phenotypes. Material and Methods Animals The animal utilization protocol (#4843) was approved by the Animal Care Committee at the University of Guelph and was in accordance with the Canadian Council on Animal Care (CCAC) for the care and handling of animals in research. Primiparous Wistar rats (RRID:RGD_13508588) at gestational Day 2 (n = 11/group; Charles River, Saint Constant, QC, Canada) were randomly allocated to the four treatment regimens: (1) AIN‐93G diet (Reeves et al. 1993) (catalog number D10012G; Research Diets, New Brunswick, NJ, USA) containing recommended vitamin (RV) content with untreated drinking water (control, CON); (2) AIN‐93G RV diet with drinking water supplemented with 0.25% betaine anhydrous (BET) (catalog number: 61962; EMD Millipore, Billerica, MA, USA); (3) modified AIN‐93G diet containing high folic acid (20 mg folic acid/kg diet) and low choline (0.5 g free choline/kg diet) with untreated drinking water (HFLC); or (4) modified AIN‐93G diet containing HFLC with drinking water supplemented with 0.25% betaine anhydrous (HFLC + BET). A simple randomization approach was used by assigning a unique identification number to each dam on an individual cage card. Using a random number generator (Random.org), the randomized output was matched to the numbered cage cards to determine treatment allocation. All treatment regimens were administered only for the duration of pregnancy. Litters were standardized within 24 h of birth by culling to a maximum 10 pups. Throughout lactation, all dams were maintained on the control diet with untreated drinking water. At weaning, 1 female and 1 male offspring from each dam were provided with an AIN‐93G RV diet formulated with 60 kcal% fat, from mostly lard, balanced for micronutrient‐to‐energy content (Research Diets, New Brunswick, NJ, USA). The modified post‐weaning diet was implemented to model the current obesogenic environment, and importantly, enabled the emergence of phenotypic differences within a shorter experimental timeframe (Cho et al. 2015, 2013). Diet composition and ingredient breakdown are presented in Table S1. The chosen dose of 0.25% betaine anhydrous corresponds to an estimated human‐equivalent intake of approximately 3 g/day, which is within the range of typical supplemental dose in other studies (Nikrandt and Chmurzynska 2024). Betaine intake amount in humans varies from 30 to 400 mg/day (Obeid 2013; Dobrijevic et al. 2023), whereas supplemental doses commonly range from 0.1–3 g/day (Nikrandt and Chmurzynska 2024), with a maximum safe dose proposed to be 15 g/day (Craig 2004). Animals were housed individually in static double‐decker cages with bedding separated by dividers (Tecniplast, West Chester, PA, USA), with food and water available ad libitum. The animal facility operated on a 12‐h:12‐h light: dark cycle (lights on at 7:00 a.m.) and animals were maintained in a temperature‐controlled room at 22°C ± 1°C. Protocol Figure 1 presents a schematic overview of the study protocol. To assess energy balance, we utilized the Comprehensive Lab Animal Monitoring System (RRID:SCR_016718; CLAMS; Columbus Instruments, Columbus, OH, USA) at 6 and 11 weeks post‐weaning to measure activity (locomotion and rearing) and short‐term food intake in a random subset of male and female offspring (n = 4–6/sex/group). Animals were acclimatized to the CLAMS chambers for 24 h prior to data collection. Ambulatory activity was measured along the X‐ and Y‐axis as the number of distinct infrared beam breaks per 10‐min interval over 24 h. Repetitive breaks of the same beam were included in the ambulatory count. Rearing activity was measured along the Z‐axis as the total number of vertical beam breaks. All measurements were grouped into the light and dark cycles using the CLAMS data eXamination Tool (Columbus Instruments, Columbus, OH, USA). From weaning to 12 weeks post‐weaning, body weight and food intake were measured weekly. Schematic of the study design and experimental timeline. Primiparous pregnant dams (n = 11/group) were randomly assigned to one of four groups during gestation: (1) AIN‐93G diet with recommended vitamin (RV) levels and untreated drinking water (control, CON); (2) AIN‐93G diet with RV levels and drinking water supplemented with 0.25% betaine (BET); (3) modified AIN‐93G diet with high folic acid (20 mg/kg) and low choline (0.5 g/kg) with untreated drinking water (HFLC); or (4) same modified diet with drinking water supplemented with 0.25% betaine (HFLC + BET). During lactation, all dams received the control diet and untreated water. After weaning, offspring (n = 11/group) were provided an AIN‐93G RV 60 kcal% fat diet, balanced for micronutrient‐to‐energy content, and untreated water. One female and one male per litter were monitored weekly for body weight and food intake (n = 11/group). Behavioral phenotyping was performed at 6 and 11 post‐weaning weeks using the Comprehensive Lab Animal Monitoring System (CLAMS; n = 4–6/group), followed by tissue collection at Week 12 used for analytical assays (n = 8/group). Sample Harvesting and Nucleic Acid Extraction At 12 weeks post‐weaning, offspring were fasted overnight for 8–10 h then euthanized using carbon dioxide inhalation. The carbon dioxide gradual‐fill rate was 35% of the chamber volume per minute in accordance with the CCAC revised guidance on euthanasia using carbon dioxide (CCAC 2020). Cervical dislocation was used as a secondary physical method to confirm death prior to tissue collection. Following euthanasia, brains were immediately removed and placed on ice. Whole blood was extracted after cardiac puncture and the blood tubes were immediately centrifuged to isolate plasma. Each brain was positioned in an ice‐cold stainless steel rat brain matrix (catalog number: Matrix BSRAS001‐1; Zivic Instruments, Pittsburgh, PA, USA) and sectioned coronally using a frozen sharp razor blade. The VTA and NAc were identified according to stereotaxic coordinates relative to bregma as anterior–posterior (AP), mediolateral (ML) and dorsoventral (DV) as defined in the Paxinos and Watson Rat Brain Atlas (RRID:SCR_006369; Paxinos and Watson 2014). Tissue punctures were made for the VTA (AP −5.2 to −5.6 mm, ML ±0.7–0.9 mm, DV −7.5 to −8.5 mm) and the NAc (AP +1.2 to +1.6 mm, ML ±1.3–1.5 mm, DV −6.5 to −7.5 mm). All samples were snap‐frozen and stored at −80°C until processing. Experimenters were blinded to group assignment and assessment of outcome variables through the use of codes to identify samples. The VTA and NAc tissue samples were homogenized using a rotor‐stator homogenizer (Thermo Fisher Scientific, Wilmington, DE, USA) and then divided into two pre‐weighed aliquots (~10 mg each) for mRNA analysis and for quantification of SAM and SAH concentrations. Gene Expression of Drd1, Drd2 and Comt in the VTA and NAc RNA from the VTA and NAc was extracted using the RNeasy Plus Universal Mini Kit (catalog number: 73404; Qiagen, Hilden, Germany) following the manufacturer's protocol. Nucleic acid concentration and purity were assessed with an Epoch Spectrophotometer (RRID:SCR_019741; Agilent BioTek, Santa Clara, CA, USA). The High‐Capacity cDNA Reverse Transcription Kit (#4368813; Thermo Fisher Scientific, Wilmington, DE, USA) was used to synthesize cDNA from the VTA and NAc samples on a ProFlex thermal cycler (RRID:SCR_027077; Thermo Fisher Scientific, Wilmington, DE, USA) according to the manufacturer's instructions. Real‐time polymerase chain reaction was performed with Taqman Fast Advanced Master Mix (catalog number: 4444556; Thermo Fisher Scientific, Wilmington, DE, USA) and TaqMan Gene Expression Assays (Drd1, catalog number: Rn03062203_s1; Drd2, catalog number: Rn00561126_m1; Comt, catalog number: Rn01404927_g1; Thermo Fisher Scientific, Wilmington, DE, USA) on a QuantStudio 7 Pro System (RRID:SCR_020245) at the Genomics Facility, University of Guelph. Cycling conditions were: 50°C for 2 min, 95°C for 20 s, followed by 40 cycles of 95°C for 1 s, and 60°C for 20 s. Glyceraldehyde‐3‐phosphate dehydrogenase (Gapdh, catalog number: Rn01775763_g1; Thermo Fisher Scientific, Wilmington, DE, USA) was used as the endogenous control and all reactions were performed in duplicate. Relative gene expression was calculated using the 2−ΔΔCT method in Design & Analysis Software 2 version 2.7.0 (RRID:SCR_026962; Thermo Fisher Scientific, Wilmington, DE, USA). Tissue SAM and SAH Concentrations Using our previously outlined methods (Shelp et al. 2024), pre‐weighed aliquots of the VTA and NAc samples (~10 mg each) were homogenized in ice‐cold phosphate buffered saline. This homogenate was incubated with gentle agitation at 4°C for 15 min, followed by centrifugation to obtain the supernatant for subsequent SAM and SAH analysis. Concentrations of SAM and SAH were quantified using enzyme‐linked immunosorbent assay (ELISA) kits (catalog number: MET‐5152 for SAM; catalog number: MET‐5151 for SAH; Cell Biolabs Inc., San Diego, CA, USA) in accordance with the manufacturer's protocol. Absorbance was read on an Epoch Spectrophotometer (RRID:SCR_019741; Agilent BioTek, Santa Clara, CA, USA). Values were normalized to tissue weight and the ratio of SAM:SAH was calculated to determine methylation potential. Plasma CRP Concentrations Plasma CRP concentrations were measured in offspring at 12 weeks post‐weaning using an ELISA kit (catalog number: ERCRP, Thermo Fisher Scientific, Wilmington, DE, USA) according to the manufacturer's instructions, and absorbance was measured on an Epoch Spectrophotometer (RRID:SCR_019741; Agilent BioTek, Santa Clara, CA, USA). Statistical Analyses Statistical analyses were performed using SAS 9.4 (RRID:SCR_008567; SAS Institute Inc., Cary, NC, USA). Longitudinal body weight and food intake across the 12 week post‐weaning period were analyzed using a repeated‐measures PROC MIXED model, with treatment, time and their interaction as fixed effects. Because one offspring per sex was selected from each dam, each animal represented an independent statistical unit with no nesting of multiple offspring within a litter. Repeated measures were modeled with individual animal ID specified as the subject in the repeated statement to account for within‐animal correlation across time. For cross‐sectional outcomes, a two‐factor analysis of variance (ANOVA) was performed with treatment, sex and their interaction modeled as fixed effects. Dam ID was included as a random intercept to account for clustering at the litter level. A prespecified, sex‐stratified one‐way ANOVA was utilized within females and males due to offspring sex being a blocking factor at the outset rather than a biological variable of interest, thus interpretation focused on the treatment effect and the interaction between treatment and sex. All metabolic cage assessments (locomotor activity and food intake) and termination measures (gene expression, SAM, SAH, the SAM:SAH ratio from the VTA and NAc; plasma CRP concentrations) were analyzed within this sex‐stratified one‐way ANOVA framework. Significant fixed effects were examined using Tukey's post hoc test. Assumptions of normality were assessed using the Shapiro–Wilk test. Detailed statistical results are presented in Table S2. Group sizes were determined a priori based on the primary outcome of post‐weaning food intake. Our previous studies indicated a 15% difference between control and micronutrient imbalanced group with a coefficient of variation of 10% (Mjaaseth et al. 2021). Using an alpha of 0.05% and 80% power, repeated‐measures PROC MIXED modeling indicated that a minimum of 10 animals/group was required; and n = 11/group was selected to ensure adequate power and accommodate potential attrition. Our analytical sample size of n = 8/group was based on the secondary outcome of interest, which was plasma CRP concentrations, and expected to provide 80% power to detect a 10% difference among groups, assuming a 12% coefficient of variation calculated from our pilot study. No pre‐determined exclusion criteria were established and no animals were excluded or replaced at any point during the experiment. In addition, no test for outliers was conducted. A sample size of n = 11/group was used for the repeated‐measures analyses of body weight and food intake. A randomly selected subset of n = 4–6/group was used for metabolic cage assessments, reflecting chamber availability, and termination measures were performed in a random subset of n = 8/group. Statistical significance was defined as p ≤ 0.05, and results are presented as mean ± standard error of the mean (SEM) unless otherwise stated. Results Activity Patterns and Short‐Term Food Intake in CLAMS Metabolic Chambers at 6 and 11 Weeks Post‐Weaning CLAMS metabolic chambers provide continuous, automated quantification of locomotor activity and short‐term food intake, enabling high‐resolution assessment of behavioral responses. X and Y ambulatory counts index horizontal movement across the cage floor, whereas Z total counts reflect vertical activity or rearing behavior, a proxy for exploratory engagement with the environment. Short‐term food intake represents the amount of food consumed during the CLAMS assessment. At 6 weeks post‐weaning, there was an effect of sex on X and Y ambulatory counts (p < 0.01) and Z total counts (p < 0.001) in the dark phase, with no additional significant effects. Within females and males separately, no significant differences in activity patterns and short‐term food intake were observed across the light or dark phases (Figure 2A–F). X and Y ambulatory activity, Z total activity and food intake during the light and dark phases at 6 weeks post‐weaning in female offspring (A, C, E) and male offspring (B, D, F) born to dams assigned to one of four groups during gestation: (1) AIN‐93G diet with recommended vitamin levels and untreated drinking water (control, CON); (2) AIN‐93G diet with recommended vitamin levels and drinking water supplemented with 0.25% betaine (BET); (3) modified AIN‐93G diet with high folic acid (20 mg/kg) and low choline (0.5 g/kg) with untreated drinking water (HFLC); or (4) same modified diet with drinking water supplemented with 0.25% betaine (HFLC + BET). Offspring were assessed in metabolic cages following an initial 24‐h acclimation period, with measurements collected over one light cycle and one dark cycle. Activity was quantified by X‐ and Y‐axis beam breaks, which reflect horizontal locomotor movement across the cage floor, whereas Z‐axis counts capture vertical activity (rearing). There was an effect of sex on X and Y ambulatory (p < 0.01) and Z total counts (p < 0.001) in the dark phase, with no other significant effects. Prespecified one‐way analysis of variance stratified by sex was conducted according to the study design. NS denotes no significant differences across groups within each sex. Data are displayed as mean ± SEM, n = 4–6/group. At 11 weeks post‐weaning, treatment had an effect on X and Y ambulatory counts (p < 0.01, light phase; p < 0.001, dark phase). BET, HFLC and HFLC + BET females had higher X and Y ambulatory counts during the light phase than CON females (p < 0.01), and there were no differences among BET, HFLC and HFLC + BET (Figure 3A). X and Y ambulatory counts during the dark phase were lower in HFLC and HFLC + BET females compared to BET females (p < 0.01), whereas all groups (BET, HFLC and HFLC + BET) did not differ from CON (Figure 3A). In male offspring, X and Y ambulatory counts during the light phase were higher in BET and HFLC groups compared to CON (p < 0.05), whereas HFLC + BET males did not differ from all other groups (CON, BET and HFLC; Figure 3B). X and Y ambulatory counts during the dark phase were lower in HFLC and HFLC + BET males compared to BET males (p < 0.01), with BET, HFLC and HFLC + BET not different from CON (Figure 3B). X and Y ambulatory activity, Z total activity and food intake during the light and dark phases at 11 weeks post‐weaning in female offspring (A, C, E) and male offspring (B, D, F) born to dams assigned to one of four groups during gestation: (1) AIN‐93G diet with recommended vitamin levels and untreated drinking water (control, CON); (2) AIN‐93G diet with recommended vitamin levels and drinking water supplemented with 0.25% betaine (BET); (3) modified AIN‐93G diet with high folic acid (20 mg/kg) and low choline (0.5 g/kg) with untreated drinking water (HFLC); or (4) same modified diet with drinking water supplemented with 0.25% betaine (HFLC + BET). Offspring were assessed in metabolic cages following an initial 24‐h acclimation period, with measurements collected over one light cycle and one dark cycle. Activity was quantified by X‐ and Y‐axis beam breaks, which reflect horizontal locomotor movement across the cage floor, whereas Z‐axis counts capture vertical activity (rearing). Treatment affected X and Y ambulatory counts (p < 0.01, light; p < 0.001, dark). Z total counts showed effects of treatment (p < 0.001, light; p < 0.01, dark) and sex (p < 0.01, light; p < 0.05, dark). Short‐term food intake was influenced by treatment (p < 0.0001) and sex (p < 0.05) in the light phase, and by sex (p < 0.0001) in the dark phase. Prespecified one‐way analysis of variance stratified by sex was conducted according to the study design. Groups that do not share a superscript letter differ significantly within each sex based on Tukey's post hoc test. In females, light phase X and Y ambulatory and Z total counts were higher in BET, HFLC and HFLC + BET compared to CON, with no difference among the three groups. During the dark phase, HFLC and HFLC + BET showed lower X and Y ambulatory counts than BET and Z total counts were reduced in HFLC compared to BET with no differences compared to CON. In males, light phase X and Y ambulatory counts were higher in BET and HFLC compared to CON, whereas HFLC + BET did not differ from any group. Dark phase X and Y ambulatory counts were lower in HFLC and HFLC + BET compared to BET, without differences compared to CON. Light phase Z total counts were elevated in BET, HFLC and HFLC + BET compared to CON, whereas dark phase Z counts showed no differences among groups. During the light phase, HFLC females and males showed the highest short‐term food intake, differing from BET and HFLC + BET, whereas none of the groups differed from CON. No differences in short‐term intake were observed during the dark phase. Data are displayed as mean ± SEM, n = 4–6/group. For Z total counts at 11 weeks post‐weaning, there were effects of treatment (p < 0.001, light phase; p < 0.01, dark phase) and sex (p < 0.01, light phase; p < 0.05, dark phase). BET, HFLC and HFLC + BET females displayed higher Z total counts during the light phase than CON females (p < 0.01), with no differences among BET, HFLC and HFLC + BET (Figure 3C). Z total counts in the dark phase were lower in HFLC females compared to BET females (p < 0.05), whereas HFLC + BET females did not differ from all other groups (CON, BET and HFLC; Figure 3C). In male offspring, Z total counts during the light phase were higher in BET, HFLC and HFLC + BET compared to CON (p < 0.01), and BET, HFLC and HFLC + BET did not differ from one another (Figure 3D). No significant differences in Z total counts were observed among treatment groups during the dark phase in male offspring (Figure 3D). Short‐term food intake at 11 weeks post‐weaning was affected by treatment (p < 0.0001) and sex (p < 0.05) in the light phase, and by sex (p < 0.0001) in the dark phase. HFLC females displayed higher short‐term food intake during the light phase compared to BET and HFLC + BET females (p < 0.01); however, all three groups did not differ from CON females (Figure 3E). Likewise, male offspring in the HFLC group had higher short‐term food intake during the light phase compared to BET and HFLC + BET (p < 0.01), whereas all three groups did not differ from CON (Figure 3F). No significant differences in short‐term food intake patterns were found in the dark phase for both female and male offspring (Figure 3E,F). Body Weight and Food Intake Over 12 Weeks Post‐Weaning Significant effects of treatment (p < 0.0001), time (p < 0.0001) and interaction between treatment and time (p < 0.0001) occurred for body weight across the 12‐weeks post‐weaning in female offspring (Figure 4A). For food intake, female offspring had significant effects of treatment (p < 0.0001) and time (p < 0.0001; Figure 4B) without an interaction. Male offspring had significant effects of treatment, time and their interaction for body weight and food intake (p < 0.0001 for all; Figure 4C,D). In both females and males, the HFLC group showed higher body weight and food intake compared to CON, whereas BET animals were lower than CON. In contrast, HFLC + BET did not differ from either CON or BET (Figure 4A–D). Weekly body weight and food intake over 12 weeks post‐weaning in female offspring (A, B) and male offspring (C, D) born to dams assigned to one of four groups during gestation: (1) AIN‐93G diet with recommended vitamin levels and untreated drinking water (control, CON); (2) AIN‐93G diet with recommended vitamin levels and drinking water supplemented with 0.25% betaine (BET); (3) modified AIN‐93G diet with high folic acid (20 mg/kg) and low choline (0.5 g/kg) with untreated drinking water (HFLC); or (4) same modified diet with drinking water supplemented with 0.25% betaine (HFLC + BET). A repeated‐measures model was fit using PROC MIXED with treatment, time and their interaction as fixed effects, stratified by sex according to the study design. Groups that do not share a superscript letter differ significantly within each sex based on Tukey's post hoc test. In female offspring, body weight showed significant effects of treatment, time and their interaction whereas food intake showed significant effects of treatment and time. In male offspring, significant effects of treatment, time and interaction were found for body weight and food intake. Across both sexes, HFLC had the highest body weight and food intake, whereas BET offspring had lower body weight and food intake compared to CON, and HFLC + BET did not differ from BET or CON. Data are displayed as mean ± SEM, n = 11/group. Gene Expression in the Reward Circuitry at 12 Weeks Post‐Weaning Genes representing distinct regulatory components of mesolimbic dopamine signaling were examined in the VTA and NAc. DRD1 and DRD2 represent the primary dopamine receptor subtypes in these regions, and COMT encodes a methylation‐dependent enzyme involved in dopamine metabolism, providing complementary indices of dopaminergic regulation relevant to the behavioral outcomes and methylation‐related markers assessed in this study. In the VTA, Drd1 showed effects of treatment, sex and their interaction (all p < 0.0001), Drd2 showed treatment (p < 0.01) and treatment × sex interaction effects (p < 0.05), and Comt showed a treatment effect (p < 0.0001), with no other significant effects observed. In female offspring, Drd1 and Drd2 gene expression did not differ among groups. However, Comt expression was lower in BET compared to CON, whereas HFLC and HFLC + BET did not differ from either CON or BET (p < 0.05; Figure 5A). In male offspring, Drd1 expression in the VTA was higher in both HFLC and HFLC + BET compared to CON, while BET did not differ from CON (p < 0.0001; Figure 5B). Drd2 and Comt gene expression levels in males were responsive to betaine supplementation only under the control diet, whereby BET was lower than CON, whereas HFLC and HFLC + BET did not differ from CON (p < 0.0001 for Drd2; p < 0.001 for Comt; Figure 5B). Relative gene expression of dopamine receptor 1 (Drd1), dopamine receptor 2 (Drd2) and catechol‐O‐methyltransferase (Comt) in the ventral tegmental area (VTA) and nucleus accumbens (NAc) at 12 weeks post‐weaning in female offspring (A) and male offspring (B) born to dams assigned to one of four groups during gestation: (1) AIN‐93G diet with recommended vitamin levels and untreated drinking water (control, CON); (2) AIN‐93G diet with recommended vitamin levels and drinking water supplemented with 0.25% betaine (BET); (3) modified AIN‐93G diet with high folic acid (20 mg/kg) and low choline (0.5 g/kg) with untreated drinking water (HFLC); or (4) same modified diet with drinking water supplemented with 0.25% betaine (HFLC + BET). In the VTA, Drd1 showed effects of treatment, sex and their interaction (all p < 0.0001), Drd2 showed treatment (p < 0.01) and interaction effects (p < 0.05), and Comt showed a treatment effect (p < 0.0001). In the NAc, Drd1 and Drd2 showed effects of sex (both p < 0.05) and treatment (both p < 0.0001), and Comt showed a treatment effect (p < 0.0001). Prespecified one‐way analysis of variance stratified by sex was conducted according to the study design. Groups that do not share a superscript letter differ significantly within each sex based on Tukey's post hoc test. Drd1 and Drd2 gene expression did not differ in the female VTA. Drd1 gene expression in the male VTA was higher in HFLC and HFLC + BET compared to CON, whereas BET did not differ from CON. Drd2 gene expression in the male VTA was lower in BET compared to CON, whereas no differences were found in HFLC and HFLC + BET compared to CON. Comt gene expression in the female and male VTA was lower in BET compared to CON. HFLC and HFLC + BET females did not differ in Comt gene expression in the VTA compared to CON and BET, whereas HFLC and HFLC + BET did not differ from CON only. In the NAc, Drd1 gene expression was lower in HFLC and HFLC + BET compared to CON, whereas BET did not differ from CON in females and males. Drd2 gene expression in the NAc was lower in HFLC females and males compared to CON, whereas BET and HFLC + BET did not differ from CON. Comt gene expression in the NAc was lower in BET females and males, higher in HFLC compared to CON. HFLC + BET females did not differ in Comt gene expression in the NAc from CON and BET, whereas HFLC + BET males did not differ from CON. Expression values are displayed as heatmaps normalized to CON, with darker blue on the gradient scale indicating higher relative expression; n = 8/group. In the NAc, Drd1 and Drd2 had effects of sex (both p < 0.05) and treatment (both p < 0.0001), and Comt had a treatment effect (p < 0.0001), with no additional effects detected. Drd1 gene expression levels were lower in both HFLC and HFLC + BET compared to CON, whereas BET did not differ from CON in female and male offspring (both p < 0.0001; Figure 5A,B). Drd2 expression levels were lower in HFLC compared to CON in females (p < 0.0001; Figure 5A) and males (p < 0.01; Figure 5B), while BET and HFLC + BET did not differ from CON. For Comt, expression levels were lower in BET and higher in HFLC compared to CON in both sexes (both p < 0.0001; Figure 5A,B). HFLC + BET females and males did not differ from CON in Comt gene expression, and HFLC + BET females also did not differ from BET. SAM and SAH Concentrations in the Reward Circuitry at 12 Weeks Post‐Weaning SAM and SAH concentrations were quantified in the VTA and NAc of female and male offspring, and the SAM:SAH ratio was calculated as an index of methylation potential. In the VTA, treatment significantly affected SAM (p < 0.01), whereas SAH and the SAM:SAH ratio showed no main or treatment × sex interaction effects. In both females and males, SAM concentrations were higher in BET compared to CON, whereas HFLC and HFLC + BET did not differ from either CON or BET (both p < 0.05; Figure 6A,D). SAH concentrations and the SAM:SAH ratio did not differ among groups in both sexes (Figure 6B,C,E,F). Tissue concentrations of S‐adenosylmethionine (SAM) and S‐adenosylhomocysteine (SAH), and the ratio of SAM:SAH in the ventral tegmental area (VTA) and nucleus accumbens (NAc) at 12 weeks post‐weaning in female offspring (A, B, C; G, H, I) and male offspring (D, E, F; J, K, L) born to dams assigned to one of four groups during gestation: (1) AIN‐93G diet with recommended vitamin levels and untreated drinking water (control, CON); (2) AIN‐93G diet with recommended vitamin levels and drinking water supplemented with 0.25% betaine (BET); (3) modified AIN‐93G diet with high folic acid (20 mg/kg) and low choline (0.5 g/kg) with untreated drinking water (HFLC); or (4) same modified diet with drinking water supplemented with 0.25% betaine (HFLC + BET). In the VTA, treatment affected SAM (p < 0.01) without the influence of sex or treatment × sex interaction; SAH and the SAM:SAH ratio showed no significant main or interaction effects. In the NAc, treatment affected SAM (p < 0.0001) and the SAM:SAH ratio (p < 0.001), while SAH showed no significant effects. Prespecified one‐way analysis of variance stratified by sex was conducted according to the study design. Groups that do not share a superscript letter differ significantly within each sex based on Tukey's post hoc test. In the VTA, BET female and male offspring showed higher SAM, whereas HFLC and HFLC + BET did not differ from CON or BET, with no differences in SAH and SAM:SAH across groups. In the NAc, SAM was higher in BET females and males, lower in HFLC, and unaltered in HFLC + BET compared to CON, with no differences in SAH across groups. The SAM:SAH ratio in the NAc was higher in BET compared to CON in females and males. No difference in SAM:SAH was observed in HFLC females and males compared to CON but the ratio was lower in both sexes when compared to BET. HFLC + BET did not differ from CON, BET and HFLC in females and males. Data are displayed as mean ± SEM, n = 8/group. In the NAc, there was a treatment effect on SAM (p < 0.0001) and the SAM:SAH ratio (p < 0.001), while SAH showed no significant effects of treatment, sex or treatment × sex interaction, and no additional main or interaction effects were observed for any measure. SAM concentrations were higher in BET compared to CON, lower in HFLC compared to CON, and did not differ between HFLC + BET and CON in both females and males (both p < 0.0001; Figure 6G,J). SAH concentrations did not differ among groups (Figure 6H,K). The SAM:SAH ratio was higher in BET compared to CON; HFLC did not differ from CON but was lower than BET, and HFLC+ BET did not differ from CON, BET or HFLC in both sexes (both p < 0.01; Figure 6I,L). Plasma CRP Concentrations at 12 Weeks Post‐Weaning Plasma CRP concentrations were measured to evaluate whether gestational intake of micronutrients altered systemic inflammation. There was a main effect of treatment (p < 0.0001), with no significant effects of sex or treatment × sex interaction. In both females and males, CRP concentrations were higher in HFLC compared to CON, whereas BET and HFLC + BET did not differ from CON (p < 0.0001 for females; p < 0.001 for males; Figure 7A,B). Plasma C‐reactive protein (CRP) concentrations at 12 weeks post‐weaning in female offspring (A) and male offspring (B) born to dams assigned to one of four groups during gestation: (1) AIN‐93G diet with recommended vitamin levels and untreated drinking water (control, CON); (2) AIN‐93G diet with recommended vitamin levels and drinking water supplemented with 0.25% betaine (BET); (3) modified AIN‐93G diet with high folic acid (20 mg/kg) and low choline (0.5 g/kg) with untreated drinking water (HFLC); or (4) same modified diet with drinking water supplemented with 0.25% betaine (HFLC + BET). There was a main effect of treatment (p < 0.0001), with no significant effects of sex or treatment × sex interaction. Prespecified one‐way analysis of variance stratified by sex was conducted according to the study design. Groups that do not share a superscript letter differ significantly within each sex based on Tukey's post hoc test. Plasma CRP concentrations were elevated in HFLC group compared to CON, with no difference among BET, HFLC + BET and CON for female and male offspring. Data are displayed as mean ± SEM, n = 8/group. Correlation Between Plasma CRP Concentrations and Dopaminergic Receptor Gene Expression Pearson correlation analyses were conducted to evaluate the association between CRP in relation to Drd1 and Drd2 gene expression to capture the most proximal biological link between inflammatory tone and transcriptional regulation of core dopaminergic receptors, allowing us to focus on neuroimmune modulation. Correlations were examined within females and males separately to align with the prespecified analysis stratified by sex. In female offspring, higher plasma CRP concentrations were associated with lower Drd1 and Drd2 expression in the NAc (r 2 = 0.17, p < 0.05; r 2 = 0.32, p < 0.001; Figure 8C,D). In male offspring CRP concentrations were positively associated with Drd1 expression in the VTA (r 2 = 0.21, p < 0.01; Figure 8E) and negatively associated with Drd1 expression in the NAc (r 2 = 0.15, p < 0.05; Figure 8G). No other associations across sex and brain regions were detected. Correlations between plasma C‐reactive protein (CRP) concentrations and relative gene expression of dopamine receptor 1 (Drd1), dopamine receptor 2 (Drd2) in the ventral tegmental area (VTA) and nucleus accumbens (NAc) at 12 weeks post‐weaning in female offspring (A, B, C, D) and male offspring (E, F, G, H). Pearson correlation analysis revealed patterns that varied across regions in mesolimbic circuitry within each sex. In female offspring, CRP was negatively correlated with Drd1 and Drd2 expression in the NAc (r 2 = 0.17, p < 0.05; r 2 = 0.32, p < 0.001). In male offspring, CRP was positively correlated with Drd1 expression in the VTA (r 2 = 0.21, p < 0.01) and negatively correlated with Drd1 in the NAc (r 2 = 0.15, p < 0.05). Lines indicate linear regression fits; n = 8/group. Discussion The findings from this study supported our hypothesis that prenatal micronutrient composition shapes long‐term neurobehavioral and immunometabolic outcomes, with betaine as a modifier of some of these effects. Our key results included: (1) micronutrient imbalance, betaine alone, and betaine with the imbalance produced distinct behavioral signatures across the light–dark cycle and modulated offspring body weight and food intake; (2) dopaminergic receptor expression within mesolimbic regions, along with Comt and associated methylation markers, were responsive to prenatal micronutrient exposure, with localized treatment × sex interactions restricted to the VTA; and (3) female and male offspring exposed to high folic acid and low choline exhibited elevated CRP, that was not modified by betaine, with correlation analyses indicating a selective relationship between inflammation and dopaminergic receptor measures. Light and dark phase activity patterns revealed unique behavioral signatures of micronutrient imbalance and betaine supplementation. Rather than producing early behavioral differences at 6 weeks post‐weaning, prenatal exposures altered locomotor and food intake patterns only later in the post‐weaning period at 11 weeks, coinciding with the separation of long‐term body weight and food intake measures among groups. The most striking pattern was the elevation in X and Y ambulatory counts and Z total activity in the light phase among BET, HFLC and HFLC + BET offspring across sexes. Notably, only HFLC exhibited higher food intake, suggesting that heightened activity in this group reflected movement associated with increased consumption, which contrasts BET and HFLC + BET, where activity increased without changes in intake. Because rodents are nocturnal, elevated light phase feeding suggests a disruption in feeding‐related regulation (la Fleur et al. 2024). In the dark phase, food intake behavior did not differ among groups, but activity diverged, whereby betaine‐exposed offspring showed higher activity, while those exposed to the imbalanced high folic acid and low choline showed reduced counts. This pattern indicates that prenatal micronutrient differences can shift movement without necessarily altering feeding behavior in the active phase. Sex‐specific effects were also apparent, with Z total activity differing in females but not males, mirroring the direction of X and Y ambulatory counts in response to betaine supplementation or micronutrient imbalance. Importantly, betaine supplementation mitigated the reduced activity associated with the imbalanced diet, indicating a potential protective effect on movement‐related behaviors that is both sex‐ and phase‐specific. In line with this, other work has identified betaine as a potential exercise mimetic for healthy aging (Geng et al. 2025), albeit under a study design that differs from ours. Overall, activity patterns in the dark phase and food intake in the light phase did not differ from untreated controls, implying that these 12‐h snapshots captured subtle behavioral shifts. The more pronounced long‐term differences in body weight and food intake likely reflect integrated metabolic alterations that extend beyond acute behavioral measures, as accumulated outcomes that can determine permanent phenotypes (Ahmed and Mohammed 2025). Prenatal betaine exposure resulted in lower body weight and food intake than untreated controls, and appeared to attenuate the elevations under the imbalanced micronutrient (high folic acid, low choline) regimen. Although this imbalance was less severe than our previously used high folic acid and no choline condition (Shelp et al. 2024; Chen et al. 2023; Mjaaseth et al. 2021), it still produced higher body weight and food intake relative to control, indicating that even moderate mismatches may be sufficient to produce divergent metabolic phenotypes. Betaine alone reduced body weight and food intake compared to untreated controls, whereas adding betaine to the high folic acid, low choline imbalance did not reproduce the full effect of betaine alone, as seen with HFLC + BET that did not differ from CON or BET. The metabolic benefits of betaine have emerged recently across various models (Kathirvel et al. 2024; Joselit et al. 2018; Lim et al. 2025; Wang et al. 2025; Sivanesan et al. 2018; Du et al. 2018; Mlodzik‐Czyzewska et al. 2025) and have been discussed in reviews (Arumugam et al. 2021; Nikrandt and Chmurzynska 2024; Dobrijevic et al. 2023). Our study stands out by providing central mechanisms of betaine, and its ability to confer health effects may depend on the nature of existing micronutrient imbalances. Dopaminergic receptor gene expression within the mesolimbic reward circuitry was amenable to prenatal micronutrient exposure, with two localized treatment × sex interactions emerging in the VTA. Both Drd1 and Drd2 expression differed in male but not female offspring, suggesting that the dopaminergic system in males may be more responsive to prenatal micronutrients. Although the study was not designed to elucidate mechanisms underlying sex differences, several previously described developmental features could plausibly contribute to this pattern. The VTA undergoes sex‐biased maturation shaped by early gonadal hormone exposure and sex chromosome‐linked transcriptional programming, which can modulate dopaminergic receptor expression and susceptibility to metabolic or nutritional perturbations (Gillies et al. 2014; Price and Polter 2025). Although not directly comparable, recent work revealed that males can recruit additional excitatory mechanisms to preserve dopaminergic output following stress, whereas females do not engage this compensatory pathway (Bouarab et al. 2025). In our study, the selective reduction of Drd2 gene expression in males exposed to prenatal betaine supplementation compared to control may reflect a related mode of sex‐specific metabolic responsiveness concurrent with diminished reward‐driven behaviors. Additional complexity is evident in higher Drd1 expression observed in males from both HFLC and HFLC + BET groups compared to control, without changes in Drd2, implying that under conditions of folic acid‐choline imbalance, the capacity of betaine to normalize dopaminergic receptor expression may be limited within the VTA. In the NAc, prenatal micronutrient composition produced distinct receptor gene expression profiles without treatment × sex interactions. Drd1 expression was lower in both HFLC and HFLC + BET females and males, indicating that the effects of imbalanced micronutrient conditions extended to both sexes, with betaine providing no restoration of receptor expression. In contrast, the reduction in Drd2 expression observed in HFLC females and males returned to control levels in HFLC + BET offspring, suggesting that betaine exerts receptor‐specific modulation of dopaminergic signaling within the reward circuitry. Notably, both higher and lower receptor expression levels have been described in the context of obesity with varied functional outcomes (Hukema et al. 2025; Alsio et al. 2010; Beeler et al. 2016; Vucetic et al. 2012; Carlin et al. 2013), highlighting that shifts in Drd1 and Drd2 expression may have complex behavioral implications. Reduced receptor expression may reflect dampened dopamine signaling and lower sensitivity to natural reward, potentially driving compensatory overconsumption, which has been proposed as the reward deficiency hypothesis (Blum et al. 2012). Conversely, elevated receptor expression may indicate heightened reward sensitivity and an amplified hedonic drive that promotes food‐seeking behavior (Hukema et al. 2025). In our study, HFLC offspring showed increased food consumption accompanied by increased activity, whereas HFLC + BET and BET offspring exhibited lower food intake but similarly elevated activity relative to CON. This divergence suggests that activity associated with overeating may differ from activity that occurs independent of food intake, potentially through different configurations of dopaminergic receptor gene expression that contribute to distinct motivational states (Bromberg‐Martin et al. 2010). Diet‐induced alterations in the dopaminergic system have also been proposed as a mechanism contributing to physical inactivity in obesity (Kravitz et al. 2016). However, the present study cannot distinguish whether dopaminergic changes arise directly from the diet or secondarily from diet‐induced obesity (Wallace and Fordahl 2022). Serial measurements across developmental time points, along with pair‐feeding designs, would help clarify the specific stimuli driving these expression changes. COMT represents an upstream regulatory mechanism that shapes dopaminergic receptor pathways (Tunbridge 2010), and prenatal micronutrient composition acted as a modulator of Comt gene expression. Across the VTA and NAc, prenatal betaine supplementation reduced Comt gene expression, which, together with altered Drd1 and Drd2 expression, may have shifted the dopaminergic balance, consistent with lower intake behavior and higher activity. The imbalanced micronutrient condition produced divergent Comt gene expression profiles, such that levels did not differ from CON or BET in the female VTA, and did not differ from CON in the male VTA, whereas levels were higher than CON in the NAc in both female and male offspring. In accordance, Comt gene expression in HFLC + BET females and males did not diverge from that of HFLC in the VTA but did so in the NAc. These patterns suggest that the NAc, the primary recipient and integrator of dopaminergic input driving reward‐seeking behavior (Xu et al. 2024), may be more sensitive to micronutrient‐driven programming than the upstream dopaminergic source in the VTA. The relative magnitude of gene expression changes also varied across sex, for example BET produced less than 50% reduction in Comt gene expression in the male NAc as opposed to greater than 50% reduction in the female NAc, and in comparison, HFLC + BET correspondingly brought Comt gene expression levels toward the BET group in the female NAc (but not in males). Together, these findings highlight distinct Comt expression patterns associated with prenatal micronutrient exposure within reward circuitry, aligning with broader shifts in dopaminergic system regulation. SAM and the SAM:SAH ratio shifted in parallel to Comt gene expression of offspring exposed of dams with varying micronutrient intake. Although SAM differed across groups, SAH concentrations were unchanged in the VTA and NAc. This study provides the first direct comparison of SAM and SAH in reward‐related regions, extending beyond the whole brain. The absence of SAH differences contrasts with our earlier findings (Shelp et al. 2024) and may reflect the narrower micronutrient imbalance and/or tissue specificity in the current study design compared with the maximal imbalance previously tested in the hypothalamus (Shelp et al. 2024). Moreover, the SAM:SAH ratio did not vary in the VTA, despite differences in SAM, suggesting that this region may be relatively stable against micronutrient imbalance, potentially through homeostatic regulation of methyl donor availability (Williams and Schalinske 2007). In the NAc, the SAM:SAH ratio largely corresponded with changes in SAM, even though SAH remained unchanged, indicating that SAM availability appears to be a primary driver of methylation potential in this model. This heightened responsiveness aligns with the well‐established role of the NAc in motivation and reward (Xu et al. 2024), and with recent evidence revealing brain‐region specific DNA methylation signatures (Rizzardi et al. 2019). Notably, female and male offspring displayed analogous patterns in SAM, SAH and SAM:SAH, suggesting that treatment effects, rather than sex‐specific programming, were the dominant influence on methylation potential. We demonstrate for the first time that CRP was elevated under imbalanced micronutrient conditions, suggesting potential long‐term programming of inflammatory marks. SAM has previously been proposed to suppress cytokine production (Pfalzer et al. 2014), and because betaine serves as a methyl donor that can increase SAM production in one‐carbon cycle (Craig 2004), these findings point to a possible link between methyl donor availability and inflammation. No change in CRP was observed in BET and HFLC + BET compared to CON, indicating that betaine alone did not reduce CRP but did ameliorate the elevation seen under HFLC conditions. This pattern suggests the modulatory capacity afforded by betaine may depend on the presence of a disrupted methylation environment rather than having broad anti‐inflammatory effects. The associations between CRP and dopaminergic receptor expression further indicate that inflammation offers an additional dimension for deciphering the role of early nutritional exposure in shaping reward‐related neurobiology (Bolton and Bilbo 2014). Notably, the direction and regional specificity of these associations differed by sex, with CRP negatively associated with Drd1 and Drd2 in the female NAc, whereas CRP was positively associated with Drd1 in the VTA and negatively associated with Drd1 in the NAc in males, consistent with prior evidence that males and females engage different neuroimmune strategies when responding to stressors (Osborne et al. 2018). Both the positive and negative correlation between CRP and Drd1 in different reward‐related regions suggest that the regulation of dopaminergic pathways may be dependent on local neurocircuitry. We should also acknowledge that SAM was measured in specific regions of the reward pathway, whereas CRP was measured in plasma, reflecting the peripheral milieu or broader central compartment (Felger et al. 2020). Thus, caution is required as the neural microenvironment may differ, and additional factors beyond SAM may have influenced CRP levels. Extending further, our findings generally converge with recent evidence connecting DNA methylation‐based scores as a proxy for inflammation with reduced striatal DRD2 availability in aging selectively for older male adults (Crine et al. 2025). Higher plasma CRP concentrations in patients with major depressive disorder have similarly been found concurrently with lower functional connectivity within reward circuitry, and correlated with symptoms of anhedonia (Felger et al. 2016). In addition, peripheral administration of inflammatory stimuli can alter neural activity in reward circuitry (Felger et al. 2013), supporting the role of inflammatory mediators in brain outcomes with functional implications. Although CRP served as a systemic indicator of inflammatory tone, several additional neuroimmune markers interface with dopaminergic signaling (Li et al. 2022). A broader systemic cytokine panel such as interleukin (IL)‐6, IL‐1β, tumor necrosis factor (TNF)‐α, monocyte chemoattractant protein‐1 (MCP‐1) and IL‐10, would provide a more comprehensive characterization of metabolic inflammation (Felger and Treadway 2017). Moreover, cellular mediators that influence dopaminergic neuron excitability, receptor expression and reward‐related behavior such as IL‐6, IL‐1β and TNF‐α should also be considered (Felger and Miller 2012), alongside markers of microglial phenotypes such as ionized calcium‐binding adaptor molecule‐1 (Iba‐1) for microglia and glial fibrillary acidic protein (GFAP) for astrocytes to capture local neuroimmune status within dopaminergic regions (Sochocka et al. 2017). While these markers were beyond the scope of the present study, they represent complementary future directions that could refine understanding of the potential neuroimmune signaling mechanisms in relation to early‐life exposure to one‐carbon nutrients. This study had many strengths, including brain region‐specific insights into the regulation of complex behavior. Further, the use of two time points for metabolic cages was advantageous in capturing changes over time. Conversely, this study also had certain limitations. Tissue collection was performed at 12 weeks post‐weaning, whereas metabolic cage assessments were conducted at 6 and 11 weeks post‐weaning. Direct linkage between functional and molecular measures is precluded, as such inference would require serial tissue collections across developmental stages. Further, gene expression levels in the VTA and NAc were assessed using bulk tissue without distinguishing between subregions (e.g., the core or shell of the NAc), which have been suggested to produce functional differences (Mai et al. 2015); thus, the study findings indicate overall rather than within site‐specific patterns. As our analyses were limited to mRNA expression, the absence of protein‐level measurements or dopamine receptor binding constrains our ability to make definitive statements about broader alterations in mesolimbic circuitry. In addition, we were unable to examine correlations between gene expression and CLAMS‐derived activity because the smaller CLAMS sample size (n = 4–6/group) provided insufficient power for stable correlation estimates. Larger cohorts will be needed to evaluate links between behavioral activity and transcriptional endpoints. Finally, the VTA and NAc make projections to other regions of the brain including the hypothalamus and prefrontal cortex (Berthoud and Morrison 2008), thus leveraging these connections will define how dopaminergic system shapes metabolic phenotypes. An integrative view across other neurocircuits (Schwartz et al. 2000) and the peripheral system (Dong, Al‐Issa, et al. 2025) is needed to clarify energy balance and fully delineate the interplay between the reward pathways and homeostatic regulation (Baik 2021). Conclusions This work identifies that prenatal methyl nutrient composition may modify mesolimbic function, linking one‐carbon metabolism to dopaminergic system and inflammatory signal in female and male offspring. Broadly, these results emphasize the potential for early life environment as a regulator of long‐term health trajectory with betaine having a protective role in the context of prenatal nutritional imbalance. Author Contributions Cassia Di Pierdomenico: methodology, investigation, writing – original draft; William J. J. Cook: methodology, data curation, investigation, formal analysis; Jianzhang Dong: methodology, investigation; Gia V. Shelp: methodology, investigation; Elizabeth M. Poole: methodology, investigation; Sarah E. Burns: methodology, investigation; Clara E. Cho: conceptualization, formal analysis, supervision, writing – original draft. Funding This work was supported by the Natural Sciences and Engineering Research Council of Canada‐Discovery Grant and University of Guelph Team Building Grant. GVS was supported by a Canadian Institutes of Health Research (CIHR) Canada Graduate Scholarship‐Master. CEC holds a CIHR Canada Research Chair (Tier II). Disclosure No AI tools have been used in the development of the manuscript. Conflicts of Interest The authors declare no conflicts of interest. Supporting information Table S1: Composition and ingredient breakdown of the gestational AIN‐93G diet with recommended vitamin content (RV), the gestational modified AIN‐93G diet containing high folic acid (20 mg folic acid/kg diet) and low choline (0.5 g free choline/kg diet) content (HFLC), and the post‐weaning modified AIN‐93G RV diet containing 60 kcal% fat, from mostly lard, balanced for micronutrient‐to‐energy content. Table S2: Detailed statistical values for Figures 2–8.